Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 50   

Articles published

GSK 1,365.50 -6.00 (-0.44%)
price chart
US top court rules for Glaxo on overtime pay
By a 5-4 vote, the high court handed a defeat to two former sales representatives for a unit of Britain's GlaxoSmithKline Plc. They had appealed a U.S. appeals court in California ruling that they were "outside sales" personnel exempt from federal ...
GSK Receives FDA Approval for MenHibrix�
PHILADELPHIA, June 14, 2012 /PRNewswire/ -- GlaxoSmithKline plc (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix� [Meningococcal Groups C and Y and Haemophilus b Tetanus ...
US approves Glaxo meningitis vaccine for children  Fox News
KineMed Announces Biomarker Discovery Collaboration with GSK
EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. ( announced today a multi-year R&D collaboration with GlaxoSmithKline plc (GSK) (LSE: GSK, NYSE: GSK) that will apply KineMed's proprietary biomarker discovery platform in ...
Glaxo to Pay at Least $226 Million for Basilea's Toctino
GlaxoSmithKline Plc agreed to buy the marketing rights for Basilea Pharmaceutica AG's hand eczema drug Toctino for 146 million pounds ($226 million).
Glaxo CEO Says Europe Market 'Much' Worse Than Expected
GlaxoSmithKline Plc Chief Executive Officer Andrew Witty said, “What we've seen in the last three, four months is a much higher level of price pressure than we had anticipated, which is of course making short-term trading more challenging than expected.
Should investors embrace the profits of sin?
Investors are equally divided on another key component of the Saints: pharmaceuticals companies. GlaxoSmithKline (GSK) and AstraZeneca (AZN) are among the highest-yielding companies in the FTSE 100, yet the rising cost of drug discoveries coupled ...
Bristol, AstraZeneca among Amylin bidders-sources
O), and a bid by GlaxoSmithKline Plc (GSK.L) to buy long-time partner Human Genome Sciences Inc HGSI.O for about $2.6 billion.
Makers' mark: why UK PLC is on the march
From world-leading companies such as GlaxoSmithKline in pharmaceuticals, BAE Systems in defence technology and Burberry in fashion, "Made in Britain" is still a label to be proud of, but there is less of it around than there used to be.
No Overtime for Drug Reps
Monday's decision came in a case involving GlaxoSmithKline PLC, which was fighting legal claims from two former salesmen who were seeking overtime pay on behalf of a nationwide class of representatives employed by the drug maker.
It's time to get over the gilt complex
The unending flight to quality in sovereign bonds has seen gilt prices soar and yields sink to levels that have rarely, if ever, been seen.